Trends & Insights

Digital

Trends outside the headlines, people reviewing graphs

Trends & Insights: February 2026 – A pharmaphorum industry r...

February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.

Digital

Trends & Insights, January 2026: A pharmaphorum industry rep...

Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.

News

Avalyn seeks $300m from its IPO

Pulmonary fibrosis drug developer Avalyn prices its IPO at around $300m, as Seaport and Hemab both target $180m-plus from their listings.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks